RGABX
Price
$67.15
Change
+$0.60 (+0.90%)
Updated
Dec 20 closing price
RGEBX
Price
$72.22
Change
+$0.65 (+0.91%)
Updated
Dec 20 closing price
Ad is loading...

RGABX vs RGEBX

Header iconRGABX vs RGEBX Comparison
Open Charts RGABX vs RGEBXBanner chart's image
American Funds Growth Fund of Amer R2
Price$67.15
Change+$0.60 (+0.90%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$72.22
Change+$0.65 (+0.91%)
VolumeN/A
CapitalizationN/A
RGABX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGABX vs. RGEBX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGABX is a Buy and RGEBX is a Buy.

FUNDAMENTALS
Fundamentals
RGABX (301B) and RGEBX (301B) have equal amount of cash in the bank . RGEBX pays higher dividends than RGABX: RGEBX (0.16) vs RGABX (0.00). RGABX was incepted earlier than RGEBX: RGABX (23 years) vs RGEBX (10 years). RGABX (31.00) and RGEBX (31.00) have comparable annual turnover. RGABX (250) and RGEBX (250) have matching initial minimum investment requirements. RGEBX annual gain was more profitable for investors over the last year : 19.08 vs. RGABX (18.01). RGEBX return over 5 years is better than : 44.55 vs. RGABX (39.75).
RGABXRGEBXRGABX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD17.62118.66694%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets301B301B100%
Annual Yield % from dividends0.000.16-
Returns for 1 year18.0119.0894%
Returns for 3 years0.452.6217%
Returns for 5 years39.7544.5589%
Returns for 10 years62.2469.2490%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PL4.040.16
+4.12%
Planet Labs PBC
FIVN42.631.15
+2.77%
Five9
VEEV224.154.48
+2.04%
Veeva Systems
PRQR2.630.04
+1.54%
ProQR Therapeutics NV
BIVI1.90-0.18
-8.65%
BioVie Inc